BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hanif S, Muhammad P, Niu Z, Ismail M, Morsch M, Zhang X, Li M, Shi B. Nanotechnology‐Based Strategies for Early Diagnosis of Central Nervous System Disorders. Adv NanoBio Res 2021;1:2100008. [DOI: 10.1002/anbr.202100008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Conklin B, Conley BM, Hou Y, Chen M, Lee KB. Advanced theragnostics for the central nervous system (CNS) and neurological disorders using functional inorganic nanomaterials. Adv Drug Deliv Rev 2023;192:114636. [PMID: 36481291 DOI: 10.1016/j.addr.2022.114636] [Reference Citation Analysis]
2 Rehman FU, Khattak S, Mumtaz S, Hanif S, Muhammad P. Hybrid platforms for drug delivery applications. Novel Platforms for Drug Delivery Applications 2023. [DOI: 10.1016/b978-0-323-91376-8.00002-1] [Reference Citation Analysis]
3 Gautam A. Towards Modern-Age Advanced Sensors for the Management of Neurodegenerative Disorders: Current Status, Challenges and Prospects. ECS Sens Plus 2022;1:042401. [DOI: 10.1149/2754-2726/ac973e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Azimi Sanavi M, Mahdavian F, Dorosti N, Karami N, Karami S, Khatami SH, Vakili O, Taheri-Anganeh M, Karima S, Movahedpour A. A review of highly sensitive electrochemical genosensors for microRNA detection: A novel diagnostic platform for neurodegenerative diseases diagnostics. Biotechnol Appl Biochem 2022. [PMID: 36445196 DOI: 10.1002/bab.2419] [Reference Citation Analysis]
5 Dessale M, Mengistu G, Mengist HM. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis. Int J Nanomedicine 2022;17:3735-49. [PMID: 36051353 DOI: 10.2147/IJN.S378074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Yan J, Hanif S, Zhang D, Ismail M, Wang X, Li Q, Shi B, Muhammad P, Wu H. Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy. ACS Appl Mater Interfaces 2022. [PMID: 35921662 DOI: 10.1021/acsami.2c12076] [Reference Citation Analysis]
7 Muhammad P, Hanif S, Li J, Guller A, Rehman FU, Ismail M, Zhang D, Yan X, Fan K, Shi B. Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway. Nano Today 2022;45:101530. [DOI: 10.1016/j.nantod.2022.101530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
8 Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol 2022:S1044-579X(22)00155-9. [PMID: 35779712 DOI: 10.1016/j.semcancer.2022.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ismail M, Yang W, Li Y, Chai T, Zhang D, Du Q, Muhammad P, Hanif S, Zheng M, Shi B. Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121608] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]